151 related articles for article (PubMed ID: 8359922)
1. Clostridium difficile toxin A elicits Ca(2+)-independent cytotoxic effects in cultured normal rat intestinal crypt cells.
Fiorentini C; Donelli G; Nicotera P; Thelestam M
Infect Immun; 1993 Sep; 61(9):3988-93. PubMed ID: 8359922
[TBL] [Abstract][Full Text] [Related]
2. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.
Lima AA; Lyerly DM; Wilkins TD; Innes DJ; Guerrant RL
Infect Immun; 1988 Mar; 56(3):582-8. PubMed ID: 3343050
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization.
Fiorentini C; Malorni W; Paradisi S; Giuliano M; Mastrantonio P; Donelli G
Infect Immun; 1990 Jul; 58(7):2329-36. PubMed ID: 2114363
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
6. The effects of Clostridium difficile crude toxins and purified toxin A on stripped rabbit ileal mucosa in Ussing chambers.
Mitchell TJ; Ketley JM; Burdon DW; Candy DC; Stephen J
J Med Microbiol; 1987 May; 23(3):199-204. PubMed ID: 2856844
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
8. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.
Leslie JL; Huang S; Opp JS; Nagy MS; Kobayashi M; Young VB; Spence JR
Infect Immun; 2015 Jan; 83(1):138-45. PubMed ID: 25312952
[TBL] [Abstract][Full Text] [Related]
9. Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.
Giry M; Popoff MR; von Eichel-Streiber C; Boquet P
Infect Immun; 1995 Oct; 63(10):4063-71. PubMed ID: 7558320
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of Clostridium difficile toxins on ion secretion and cell integrity in human intestinal cells.
Buccigrossi V; Lo Vecchio A; Marano A; Guarino A
Pediatr Res; 2019 Jun; 85(7):1048-1054. PubMed ID: 30851723
[TBL] [Abstract][Full Text] [Related]
11. Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats.
Castagliuolo I; Karalis K; Valenick L; Pasha A; Nikulasson S; Wlk M; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G539-45. PubMed ID: 11254479
[TBL] [Abstract][Full Text] [Related]
12.
Dong L; Tomassen MM; Ariëns RMC; Oosterink E; Wichers HJ; Veldkamp T; Mes JJ; Govers C
Food Funct; 2021 Oct; 12(19):9248-9260. PubMed ID: 34606540
[TBL] [Abstract][Full Text] [Related]
13. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
14. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
Sutton PA; Li S; Webb J; Solomon K; Brazier J; Mahida YR
Clin Exp Immunol; 2008 Sep; 153(3):439-47. PubMed ID: 18505424
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
17. Role of Clostridium difficile toxins in disease.
Wilkins TD
Gastroenterology; 1987 Aug; 93(2):389-91. PubMed ID: 3596176
[No Abstract] [Full Text] [Related]
18. Epidermal growth factor attenuates Clostridium difficile toxin A- and B-induced damage of human colonic mucosa.
Riegler M; Sedivy R; Sogukoglu T; Castagliuolo I; Pothoulakis C; Cosentini E; Bischof G; Hamilton G; Teleky B; Feil W; Lamont JT; Wenzl E
Am J Physiol; 1997 Nov; 273(5):G1014-22. PubMed ID: 9374697
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
Hecht G; Pothoulakis C; LaMont JT; Madara JL
J Clin Invest; 1988 Nov; 82(5):1516-24. PubMed ID: 3141478
[TBL] [Abstract][Full Text] [Related]
20. Construction and expression of the complete Clostridium difficile toxin A gene in Escherichia coli.
Phelps CJ; Lyerly DL; Johnson JL; Wilkins TD
Infect Immun; 1991 Jan; 59(1):150-3. PubMed ID: 1987027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
